Synthesis of RAFT polymers as bivalent inhibitors of cholera toxin†
Abstract
We report a new strategy to develop low molecular weight (18–28 kDa) poly(N-acryloylmorpholine) (PNAM) polymers as bivalent inhibitors of cholera toxin (CT) using Reversible Addition–Fragmentation chain Transfer (RAFT) technology. The inhibitory activity of the galacto-conjugated polymers was examined (ELISA) and the series displayed moderate inhibitory activity (millimolar IC50).